Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cidara Thera
(NQ:
CDTX
)
20.40
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cidara Thera
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via
Benzinga
Cidara Therapeutics' Unique Cloudbreak Platform And Its Promise In Influenza And Oncology
November 14, 2024
CDTX sold its Rezayo business to concentrate on its MDC-producing Cloudbreak platform which has already produced several promising drug candidates, like CD388, a very promising clinical-stage...
Via
Talk Markets
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
November 08, 2024
Via
Benzinga
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 13, 2024
CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
CDTX Stock Earnings: Cidara Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
CDTX stock results show that Cidara Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Cidara Therapeutics (CDTX) Stock Is Falling
April 22, 2024
Cidara Therapeutics shares are trading lower by 24.4% Monday afternoon. The company announced a 1-for-20 reverse stock split.
Via
Benzinga
6 Analysts Have This to Say About Cidara Therapeutics
May 12, 2023
Via
Benzinga
Recap: Cidara Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Analyst Ratings for Cidara Therapeutics
April 18, 2023
Via
Benzinga
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 25, 2024
Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning!
Via
InvestorPlace
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
April 25, 2024
Via
Benzinga
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 23, 2024
Via
Benzinga
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
April 23, 2024
Via
Benzinga
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023
April 22, 2024
CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 25, 2023
Via
Benzinga
Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher
September 06, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Wednesday. The Dow traded down 0.57% to 34,443.02 while the NASDAQ fell 1.19% to 13,853.60. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 06, 2023
Via
Benzinga
Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?
September 06, 2023
Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to pr
Via
Benzinga
Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 06, 2023
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple...
Via
Benzinga
Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now
August 28, 2023
While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator.
Via
InvestorPlace
Cidara Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
August 09, 2023
The Dow Jones closed lower by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Janssen To Discontinue Internal Development Of Cidara Therapeutics-Partnered Influenza Candidate
July 21, 2023
Cidara Therapeutics Inc (NASDAQ: CDTX) provided an update on the status of its ongoing CD388 program for the prevention of influenza A and B under an exclusive worldwide license and collaboration...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 22, 2023
Via
Benzinga
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 12, 2023
Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...
Via
Benzinga
Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
May 12, 2023
Gainers Getaround, Inc. (NYSE: GETR) shares surged 112% to $0.7020 in pre-market trading. Getaround acquired substantially all assets of HyreCar for an aggregate purchase price of $9.45 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 12, 2023
It's time for another dive into the biggest pre-market stock movers traders need to know about as we cover the winners and losers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 28, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.